Inventor
FAIRHURST ROBIN ALEC
GB43 patents
⚠️ This page may combine multiple inventors who share the name “FAIRHURST ROBIN ALEC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
20 patentsUS6878721B1Apr 12, 2005
Beta2-adrenoceptor agonists
NOVARTIS AG29 citations96
US6800643B2Oct 5, 2004
Mixtures for organic compounds for the treatment of airway diseases
NOVARTIS AG59 citations95
US6087490AJul 11, 2000
Dinucleotide and oligonucleotide analogues
NOVARTIS AG16 citations82
US8865894B2Oct 21, 2014
Oxazolidin-2-one compounds and uses thereof
NOVARTIS AG10 citations81
US7989458B2Aug 2, 2011
Pyrimidine derivatives as alk-5 inhibitors
NOVARTIS AG12 citations81
US7008951B2Mar 7, 2006
Mixtures or organic compounds for the treatment of airway diseases
NOVARTIS AG5 citations73
US10130629B2Nov 20, 2018
Pharmaceutical combinations
NOVARTIS AG3 citations71
US7745462B2Jun 29, 2010
Quinoline-2-one derivatives for the treatment of airways diseases
NOVARTIS AG7 citations71
US6919337B2Jul 19, 2005
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
NOVARTIS AG9 citations69
US9040559B2May 26, 2015
BETA2-adrenoceptor agonists
NOVARTIS AG0 citations52
US10786492B2Sep 29, 2020
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations51
US11229643B2Jan 25, 2022
Combinations of FGFR4 inhibitors and bile acid sequestrants
NOVARTIS AG0 citations50
US10251868B2Apr 9, 2019
Benzothiazolone compound
NOVARTIS AG0 citations50
US9913828B2Mar 13, 2018
Benzothiazolone compound
NOVARTIS AG0 citations50
US7019136B2Mar 28, 2006
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
NOVARTIS AG0 citations50
US10507201B2Dec 17, 2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations49
US10202371B2Feb 12, 2019
Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors
NOVARTIS AG0 citations47
US9623012B2Apr 18, 2017
Formulation comprising benzothiazolone compound
NOVARTIS AG1 citations47
US12226405B2Feb 18, 2025
Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
NOVARTIS AG0 citations44
US8357707B2Jan 22, 2013
2-carboxamide cycloamino ureas
NOVARTIS AG0 citations41
FAIRHURST ROBIN ALEC
11 patentsUS8227462B2Jul 24, 2012
Pyrrolidine-1,2-dicarboxamide derivatives
FAIRHURST ROBIN ALEC28 citations92
US8476268B2Jul 2, 2013
Pyrrolidine-1,2-dicarboxamide derivatives
FAIRHURST ROBIN ALEC17 citations91
US8318750B2Nov 27, 2012
Organic compounds
FAIRHURST ROBIN ALEC2 citations62
US8293753B2Oct 23, 2012
Substituted 2-carboxamide cycloamino ureas
FAIRHURST ROBIN ALEC2 citations62
US8318935B2Nov 27, 2012
Organic compounds 75074
FAIRHURST ROBIN ALEC3 citations57
US8258141B2Sep 4, 2012
Organic compounds
FAIRHURST ROBIN ALEC0 citations51
US8193164B2Jun 5, 2012
Organic compounds
FAIRHURST ROBIN ALEC1 citations51
US8071565B2Dec 6, 2011
Purine derivatives as a2a agonists
FAIRHURST ROBIN ALEC2 citations51
US9296733B2Mar 29, 2016
Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
FAIRHURST ROBIN ALEC0 citations48
US8188100B2May 29, 2012
Adenosine derivatives as A2A receptor agonists
FAIRHURST ROBIN ALEC0 citations41
US8163754B2Apr 24, 2012
Purine derivatives for use as adenosine A-2A receptor agonists
FAIRHURST ROBIN ALEC0 citations33
BUSCHMANN NICOLE
5 patentsUS9266883B2Feb 23, 2016
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE16 citations90
US9533988B2Jan 3, 2017
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE13 citations82
US9896449B2Feb 20, 2018
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE2 citations71
US9802917B2Oct 31, 2017
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
BUSCHMANN NICOLE2 citations70
US10189813B2Jan 29, 2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE0 citations51